Cargando…
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
Cannabis sativa, commonly known as marijuana, contains a pool of secondary plant metabolites with therapeutic effects. Besides Δ9-tetrahydrocannabinol that is the principal psychoactive constituent of Cannabis, cannabidiol (CBD) is the most abundant nonpsychoactive phytocannabinoid and may represent...
Autores principales: | Cassano, Tommaso, Villani, Rosanna, Pace, Lorenzo, Carbone, Antonio, Bukke, Vidyasagar Naik, Orkisz, Stanislaw, Avolio, Carlo, Serviddio, Gaetano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069528/ https://www.ncbi.nlm.nih.gov/pubmed/32210795 http://dx.doi.org/10.3389/fphar.2020.00124 |
Ejemplares similares
-
The Glucose Metabolic Pathway as A Potential Target for Therapeutics: Crucial Role of Glycosylation in Alzheimer’s Disease
por: Bukke, Vidyasagar Naik, et al.
Publicado: (2020) -
Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health
por: Bukke, Vidyasagar Naik, et al.
Publicado: (2021) -
Pharmacological Treatment of Depression in Alzheimer’s Disease: A Challenging Task
por: Cassano, Tommaso, et al.
Publicado: (2019) -
The Dual Role of Glutamatergic Neurotransmission in Alzheimer’s Disease: From Pathophysiology to Pharmacotherapy
por: Bukke, Vidyasagar Naik, et al.
Publicado: (2020) -
Metabolic reprogramming in inflammatory microglia indicates a potential way of targeting inflammation in Alzheimer's disease
por: Sangineto, Moris, et al.
Publicado: (2023)